Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $20.19M.
ENTERPRISE VALUE (EV)
$20.19M
Quince Therapeutics, Inc.
Market Cap
$7.64M
Enterprise Value (EV)
$20.19M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | $7.64M | $20.19M |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | N/A |
| Skye Bioscience, Inc. (SKYE)vs › | $7.53M | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.86M | $6.55M |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.86M | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | $4.80M |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.32M | $5.13M |
| GT Biopharma, Inc. (GTBP)vs › | $8.07M | $3.11M |
| Longeveron Inc. (LGVN)vs › | $7.21M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.10M | N/A |
Market Cap
$7.64M
Total Debt
$18.36M
Cash
$5.81M
Enterprise Value
$20.19M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
